Arcturus Therapeutics Holdings, Inc. (ARCT)
10.98
+0.56
(+5.37%)
USD |
NASDAQ |
Oct 20, 16:00
10.98
0.00 (0.00%)
After-Hours: 07:17
Arcturus Therapeutics Holdings Gross Profit (TTM) : 15.98M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.98M |
| March 31, 2026 | 39.41M |
| December 31, 2025 | 64.14M |
| September 30, 2025 | 81.92M |
| June 30, 2025 | 106.48M |
| March 31, 2025 | 127.85M |
| December 31, 2024 | 134.87M |
| September 30, 2024 | 142.08M |
| June 30, 2024 | 146.74M |
| March 31, 2024 | 101.67M |
| December 31, 2023 | 69.97M |
| September 30, 2023 | 42.58M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 4.178M |
| September 30, 2019 | 4.178M |
| June 30, 2019 | 4.178M |
| March 31, 2019 | 4.178M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 12.67M |
| June 30, 2018 | 12.62M |
| March 31, 2018 | 12.61M |
| December 31, 2017 | 12.59M |
| September 30, 2017 | -0.092M |
| June 30, 2017 | -0.065M |
| March 31, 2017 | -0.068M |
| December 31, 2016 | -0.061M |
| September 30, 2016 | -0.059M |
| June 30, 2016 | -0.061M |
| March 31, 2016 | -0.054M |
| December 31, 2015 | -0.049M |
| September 30, 2015 | -0.047M |
| June 30, 2015 | -0.039M |
| March 31, 2015 | -0.036M |
| December 31, 2014 | -0.032M |
| September 30, 2014 | -0.026M |
| June 30, 2014 | -0.019M |
| March 31, 2014 | -0.013M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Emergent BioSolutions, Inc. | 363.30M |
| Exelixis, Inc. | 2.350B |
| Ionis Pharmaceuticals, Inc. | 835.84M |
| United Therapeutics Corp. | 2.717B |